OnCore Login

Return to Trial Database

GU10-148

Phase II Trial of Gemcitabine, Cisplatin, Plus Ipilimumab as First-line Treatment for Patients With Metastatic Urothelial Carcinoma: Hoosier Cancer Research Network GU10-148

Status

Study Completed

Cancer Type(s)

Bladder

Study Contact

Publications

Phase II trial of gemcitabine and cisplatin plus ipilimumab as first-line treatment for metastatic urothelial carcinoma
  • BA Gartrell, NM Hahn, TE Hutson, G Sonpavde, RJ Hauke, A Starodub, AC Small, C-K Tsao, MD Galsky

Trial Locations

All sites in which the trial GU10-148 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278